| NCT06973720 | A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE2 | 2025-04-01 | 2026-10 | 2025-12 |
| NCT06897202 | A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM | RECRUITING | PHASE2 | 2025-03-14 | 2026-06 | 2026-04 |
| NCT06924320 | A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes | RECRUITING | PHASE1 | 2025-03-03 | 2026-01 | 2025-10 |
| NCT07022977 | A Study of MET233 in Individuals With Obesity or Overweight | RECRUITING | PHASE1, PHASE2 | 2024-11-20 | 2026-01-03 | 2025-10-24 |
| NCT06712836 | A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults with Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-10-24 | 2025-10 | 2025-08 |
| NCT06857617 | This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2024-04-01 | 2025-05 | 2025-01-03 |